Feasibility and efficacy of the Vojta therapy in subacromial impingement syndrome: a randomized controlled trial

María Lidia Juárez-Albuixech, Olga Redondo-González, Inmaculada Tello-Díaz-Maroto, Jorge Lucas Torres de la Guía, Jorge Hugo Villafañe, Carmen Jiménez-Antona

Research output: Contribution to journalArticlepeer-review

Abstract

Subacromial impingement syndrome (IS) is a common disorder associ-ated with functional impairment and disability of the shoulder. The aim of this study was to evaluate the efficacy of Vojta therapy (VT) tech-niques compared with standard therapy (ST) in patients with subacro-mial IS. A randomized controlled trial was performed, with 60 patients with IS (mean age, 61±12 years) randomized into two groups: ST (n=30) and ST plus Vojta therapy (SVT, n=30). Both received 15 treatment ses-sions over 4 weeks. Outcome measures included pain intensity, func-tionality, joint range of motion (RoM), strength, and quality of life mea-surements. The efficacy of both treatments was analysed, both com-paratively and separately, immediately after completion of treatment and after 3 months. After the intervention, both groups showed statisti-cally significant differences in visual analogue scale (P=0.001), RoM (P<0.01), and strength (P<0.001), which were also seen 3 months after the intervention. SVT is more efficient in both the short and medium term in reducing pain, improving functionality, increasing articular RoM and strength, and offering a better quality of life in IS patients.

Original languageEnglish
Pages (from-to)256-264
Number of pages9
JournalJournal of Exercise Rehabilitation
Volume17
Issue number4
DOIs
Publication statusPublished - 2021

Keywords

  • Musculoskeletal disorder
  • Pain
  • Subacromial impingement syndrome
  • Vojta therapy

ASJC Scopus subject areas

  • Physical Therapy, Sports Therapy and Rehabilitation
  • Orthopedics and Sports Medicine

Fingerprint

Dive into the research topics of 'Feasibility and efficacy of the Vojta therapy in subacromial impingement syndrome: a randomized controlled trial'. Together they form a unique fingerprint.

Cite this